Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection
Clinical trial NCT02979431 · COMPLETED
Trial details
- NCT number
- NCT02979431
- Sponsor
- Ablynx, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-11
- Primary completion
- 2018-05-25
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.